Indian Rosuvastatin Exporters: Complete Supplier Ranking with Market Share — 1314 Manufacturers (2026) — TransData Nexus

Q: Who is the largest rosuvastatin buyer importing from India?

ARROW PHARMACEUTICALS PTY LTD (AUSTRALIA) is the largest rosuvastatin importer from India with a 9.9% market share and import value of $45.8M.

Q: How many rosuvastatin buyers import from India?

There are 1314 active rosuvastatin buyers importing from India, with a combined import market of $463.3M across 13,477 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top rosuvastatin buyers from India?

The top 5 rosuvastatin buyers — ARROW PHARMACEUTICALS PTY LTD, BIOCON PHARMA INC, GLENMARK PHARMACEUTICALS INC., USA, APOTEX PTY LTD,, BGP PRODUCTS GMBH — together control 30.3% of total rosuvastatin import value from India.

Suresh Sormare

Rosuvastatin

India Pharmaceutical Trade Intelligence

$463.3M427 Suppliers143 CountriesHS 30049099

ExportsIndia → UNITED STATES42.3%India → AUSTRALIA17.2%

ImportsPUERTO RICO → India$1015.1B CHINA → India$980.1K

#1 Supplier: STRIDES PHARMA

Market Analysis: Top Importing Countries & Their Importers

1United States

United States emerges as the first largest importing country, achieving a total trade value of $196.1M through 1,895 shipments. This represents a market share of 42.3% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: United States has a diverse importer base, with their top importers including:

• BIOCON PHARMA INC - $40.7M (20.8% of country's total business)

• GLENMARK PHARMACEUTICALS INC., USA - $18.6M (9.5% of country's total business)

• GLENMARK PHARMACEUTICALS INC USA - $13.9M (7.1% of country's total business)

• AUROLOGISTICS LLC, (AUROBINDO PHARM - $9.0M (4.6% of country's total business)

• AUROLOGISTICS LLC - $9.0M (4.6% of country's total business)

• Rest of United States's importers - $104.8M (53.4% of country's total business)

Key Insight: United States demonstrates strong market positioning with an average shipment value of $103.5K, indicating premium pricing strategy compared to the market average of $34.4K.

United States is a key market for Rosuvastatin imports, representing 42.3% of total trade value.

Primary Market

Secondary Market

Buyer Segment Analysis

TransData Nexus Rosuvastatin buyer market intelligence

1Buyer Segment Analysis

The importation of Rosuvastatin from India involves various buyer segments, each with distinct purchasing behaviors:

Distributors: Entities like ARROW PHARMACEUTICALS PTY LTD (Australia) and APOTEX PTY LTD (Australia) function as intermediaries, procuring large volumes to supply pharmacies and healthcare providers. Their bulk purchasing leverages economies of scale, ensuring consistent supply chains.

Contract Manufacturers: Companies such as BIOCON PHARMA INC (United States) and GLENMARK PHARMACEUTICALS INC., USA (United States) import Rosuvastatin for formulation and packaging under their brands. Their procurement is characterized by large, regular orders aligned with production schedules.

Re-exporters: Firms like BGP PRODUCTS GMBH (Netherlands) and YUSEN LOGISTICS BENELUX BELGIUM (Belgium) import Rosuvastatin to distribute it to other markets. Their purchasing patterns are influenced by global demand and regulatory considerations.

Government Procurement: Entities such as TORRENT DO BRASIL LTDA (Brazil) may engage in government tenders to supply public healthcare systems. Their procurement is often large-scale and periodic, driven by national health policies and budget cycles.

Country-Specific Import Regulations

TransData Nexus Rosuvastatin buyer market intelligence

1Country-Specific Import Regulations

United States

1. Regulatory Authority: U.S. Food and Drug Administration (FDA).

2. Import Registration Process: Importers must submit a New Drug Application (NDA) or Abbreviated New Drug Application (ANDA) to the FDA, demonstrating the drug's safety, efficacy, and manufacturing quality.

3. Estimated Timeline: The FDA review process typically takes 10 to 12 months, though it can vary based on the application's complexity.

4. Import Tariff/Duty: Pharmaceutical products under HS Code 30049099 are generally duty-free in the U.S., but importers should verify current tariffs with U.S. Customs and Border Protection.

Australia

1. Regulatory Authority: Therapeutic Goods Administration (TGA).

2. Import Registration Process: Importers must register Rosuvastatin in the Australian Register of Therapeutic Goods (ARTG) by submitting a dossier that includes clinical data, manufacturing details, and labeling information.

3. Estimated Timeline: The TGA's evaluation process can take 12 to 18 months, depending on the submission's completeness and complexity.

4. Import Tariff/Duty: Pharmaceuticals under HS Code 30049099 are typically exempt from import duties in Australia, but importers should confirm with the Australian Border Force.

Canada

1. Regulatory Authority: Health Canada.

2. Import Registration Process: Importers must obtain a Drug Identification Number (DIN) by submitting a New Drug Submission (NDS) or Abbreviated New Drug Submission (ANDS) to Health Canada, providing evidence of the drug's safety, efficacy, and quality.

3. Estimated Timeline: The review process generally takes 12 to 18 months, subject to the submission's complexity.

Demand Drivers & Market Opportunity

TransData Nexus Rosuvastatin buyer market intelligence

1Demand Drivers & Market Opportunity

The global demand for Rosuvastatin is primarily driven by the high prevalence of cardiovascular diseases (CVDs), which remain the leading cause of mortality worldwide. According to the World Health Organization (WHO), CVDs account for approximately 17.9 million deaths annually, representing 31% of all global deaths. This significant burden underscores the necessity for effective lipid-lowering therapies like Rosuvastatin.

Government healthcare programs and the expansion of universal health coverage have further bolstered demand. Many countries have incorporated statins into their national essential medicines lists, aligning with the WHO's Model List of Essential Medicines, which includes Rosuvastatin. This inclusion facilitates procurement through tender-based purchasing systems, ensuring wider accessibility and affordability. The presence of 1,314 buyers across 143 countries, as per TransData Nexus data, reflects the extensive global reach and market opportunity for Rosuvastatin.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Common Questions — Rosuvastatin Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest rosuvastatin buyer importing from India?

Based on import volume and value, ARROW PHARMACEUTICALS PTY LTD (AUSTRALIA) leads with $45.8M in imports and a 9.9% market share — the highest of any single rosuvastatin importer. BIOCON PHARMA INC (UNITED STATES) and GLENMARK PHARMACEUTICALS INC., USA (UNITED STATES) are the next largest buyers.

QHow many companies buy rosuvastatin from India?

There are 1314 active rosuvastatin buyers importing from India, with a combined market of $463.3M across 13,477 shipments to 143 countries. The top 5 buyers hold 30.3% of total import value, while the remaining 1309 buyers handle the other 69.7%.

QWhich countries import the most rosuvastatin from India?

The top importing countries for rosuvastatin from India are United States (42.3%), Australia (17.2%), Canada (6.4%), Netherlands (4.7%), Philippines (3.8%). These markets represent the largest demand centres for Indian pharmaceutical exports of rosuvastatin, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

Buyer Segment Analysis

TransData Nexus Rosuvastatin buyer market intelligence

1Buyer Segment Analysis

The importation of Rosuvastatin from India involves various buyer segments, each with distinct purchasing behaviors:

Distributors: Entities like ARROW PHARMACEUTICALS PTY LTD (Australia) and APOTEX PTY LTD (Australia) function as intermediaries, procuring large volumes to supply pharmacies and healthcare providers. Their bulk purchasing leverages economies of scale, ensuring consistent supply chains.

Contract Manufacturers: Companies such as BIOCON PHARMA INC (United States) and GLENMARK PHARMACEUTICALS INC., USA (United States) import Rosuvastatin for formulation and packaging under their brands. Their procurement is characterized by large, regular orders aligned with production schedules.

Re-exporters: Firms like BGP PRODUCTS GMBH (Netherlands) and YUSEN LOGISTICS BENELUX BELGIUM (Belgium) import Rosuvastatin to distribute it to other markets. Their purchasing patterns are influenced by global demand and regulatory considerations.

Government Procurement: Entities such as TORRENT DO BRASIL LTDA (Brazil) may engage in government tenders to supply public healthcare systems. Their procurement is often large-scale and periodic, driven by national health policies and budget cycles.

Country-Specific Import Regulations

TransData Nexus Rosuvastatin buyer market intelligence

1Country-Specific Import Regulations

United States

1. Regulatory Authority: U.S. Food and Drug Administration (FDA).

3. Estimated Timeline: The FDA review process typically takes 10 to 12 months, though it can vary based on the application's complexity.

4. Import Tariff/Duty: Pharmaceutical products under HS Code 30049099 are generally duty-free in the U.S., but importers should verify current tariffs with U.S. Customs and Border Protection.

Australia

1. Regulatory Authority: Therapeutic Goods Administration (TGA).

3. Estimated Timeline: The TGA's evaluation process can take 12 to 18 months, depending on the submission's completeness and complexity.

4. Import Tariff/Duty: Pharmaceuticals under HS Code 30049099 are typically exempt from import duties in Australia, but importers should confirm with the Australian Border Force.

Canada

1. Regulatory Authority: Health Canada.

3. Estimated Timeline: The review process generally takes 12 to 18 months, subject to the submission's complexity.

Demand Drivers & Market Opportunity

TransData Nexus Rosuvastatin buyer market intelligence

1Demand Drivers & Market Opportunity

TransData Nexus Research · Government and regulatory sourcesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Rosuvastatin

Rosuvastatin

Who Buys Rosuvastatin from India — 1314 Importers Behind a $463.3M Market

Top Rosuvastatin Importers — Ranked by Import Value

Top Rosuvastatin Buyers & Importers

Related Analysis

Need Details?

Market Analysis: Top Importing Countries & Importers

Which companies are buying Rosuvastatin — and from which countries?

Rosuvastatin — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1United States

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Rosuvastatin Buyers & Importers

QWho is the largest rosuvastatin buyer importing from India?

QHow many companies buy rosuvastatin from India?

QWhich countries import the most rosuvastatin from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

2Australia

3Canada

4Netherlands

5Philippines

QWhat is the average import order value for rosuvastatin from India?

Analysis Methodology